Clinical trial
Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected Lungs
NCT00374517 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Withdrawn
Key facts
| NCT number | NCT00374517 |
|---|---|
| Title | Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected Lungs |
| Official title | A Phase II Clinical Trial of Pimonidazole Hydrochloride as a Hypoxia Marker in Subjects Undergoing Elective Lung Resection for Treatment-Refractory Pulmonary Tuberculosis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | International Tuberculosis Research Center |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Refractory Pulmonary Tuberculosis |
| Intervention type | Drug |
| Interventions | Pimonidazole hydrochloride |
| Enrollment | 0 |
| Start date | Sep 5, 2006 |
| Primary completion | Feb 2, 2010 |
| Completion | Feb 2, 2010 |
| First posted | Sep 11, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: